Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic Syndrome

NCT00004263 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Myelodysplastic Syndromes

Interventions

DRUG: 7-hydroxystaurosporine (UCN-01)
DRUG: Cytarabine (Ara-C)

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]